BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 24769671)

  • 1. Suppression of hepatocellular carcinoma proliferation and hepatitis B surface antigen secretion with interferon-λ1 or PEG-interferon-λ1.
    Tian S; Hui X; Fan Z; Li Q; Zhang J; Yang X; Ma X; Huang B; Chen D; Chen H
    FASEB J; 2014 Aug; 28(8):3528-39. PubMed ID: 24769671
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-HBV drugs suppress the growth of HBV-related hepatoma cells via down-regulation of hepatitis B virus X protein.
    Zhang S; Gao S; Zhao M; Liu Y; Bu Y; Jiang Q; Zhao Q; Ye L; Zhang X
    Cancer Lett; 2017 Apr; 392():94-104. PubMed ID: 28192212
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of a Novel Site-Specific Pegylated Interferon Beta for Antiviral Therapy of Chronic Hepatitis B Virus.
    Tsuge M; Uchida T; Hiraga N; Kan H; Makokha GN; Abe-Chayama H; Miki D; Imamura M; Ochi H; Hayes CN; Shimozono R; Iwamura T; Narumi H; Suzuki T; Kainoh M; Taniguchi T; Chayama K
    Antimicrob Agents Chemother; 2017 Jun; 61(6):. PubMed ID: 28373196
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatitis B Virus Small Envelope Protein Promotes Hepatocellular Carcinoma Angiogenesis via Endoplasmic Reticulum Stress Signaling To Upregulate the Expression of Vascular Endothelial Growth Factor A.
    Wu SX; Ye SS; Hong YX; Chen Y; Wang B; Lin XJ; Lin X
    J Virol; 2022 Feb; 96(4):e0197521. PubMed ID: 34910612
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Growth inhibitory effects of pegylated IFN alpha-2b on human liver cancer cells in vitro and in vivo.
    Yano H; Ogasawara S; Momosaki S; Akiba J; Kojiro S; Fukahori S; Ishizaki H; Kuratomi K; Basaki Y; Oie S; Kuwano M; Kojiro M
    Liver Int; 2006 Oct; 26(8):964-75. PubMed ID: 16953837
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of immune tolerance toward tumor-associated-antigens enables growth of human hepatoma in mice.
    Gotsman I; Israeli D; Alper R; Rabbani E; Engelhardt D; Ilan Y
    Int J Cancer; 2002 Jan; 97(1):52-7. PubMed ID: 11774243
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CRISPR/Cas9-mediated knockout of HBsAg inhibits proliferation and tumorigenicity of HBV-positive hepatocellular carcinoma cells.
    Song J; Zhang X; Ge Q; Yuan C; Chu L; Liang HF; Liao Z; Liu Q; Zhang Z; Zhang B
    J Cell Biochem; 2018 Nov; 119(10):8419-8431. PubMed ID: 29904948
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatitis B virus PreS1 facilitates hepatocellular carcinoma development by promoting appearance and self-renewal of liver cancer stem cells.
    Liu Z; Dai X; Wang T; Zhang C; Zhang W; Zhang W; Zhang Q; Wu K; Liu F; Liu Y; Wu J
    Cancer Lett; 2017 Aug; 400():149-160. PubMed ID: 28455240
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role in nude mice of interferon and natural killer cells in inhibiting the tumorigenicity of human hepatocellular carcinoma cells infected with hepatitis B virus.
    Shouval D; Rager-Zisman B; Quan P; Shafritz DA; Bloom BR; Reid LM
    J Clin Invest; 1983 Aug; 72(2):707-17. PubMed ID: 6192149
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RASSF1A expression inhibits the growth of hepatocellular carcinoma from Qidong County.
    Xue WJ; Li C; Zhou XJ; Guan HG; Qin L; Li P; Wang ZW; Qian HX
    J Gastroenterol Hepatol; 2008 Sep; 23(9):1448-58. PubMed ID: 17683489
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interferon-lambda induces G1 phase arrest or apoptosis in oesophageal carcinoma cells and produces anti-tumour effects in combination with anti-cancer agents.
    Li Q; Kawamura K; Ma G; Iwata F; Numasaki M; Suzuki N; Shimada H; Tagawa M
    Eur J Cancer; 2010 Jan; 46(1):180-90. PubMed ID: 19879751
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sustained HCV clearance by interferon-based therapy reduces hepatocellular carcinoma in hepatitis B and C dually-infected patients.
    Hung CH; Lu SN; Wang JH; Hu TH; Chen CH; Huang CM; Lee CM
    Antivir Ther; 2011; 16(7):959-68. PubMed ID: 22024511
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inducing oral immune regulation of hepatitis B virus envelope proteins suppresses the growth of hepatocellular carcinoma in mice.
    Gotsman I; Alper R; Klein A; Rabbani E; Engelhardt D; Ilan Y
    Cancer; 2002 Jan; 94(2):406-14. PubMed ID: 11900226
    [TBL] [Abstract][Full Text] [Related]  

  • 14. JS-K, a nitric oxide prodrug, induces DNA damage and apoptosis in HBV-positive hepatocellular carcinoma HepG2.2.15 cell.
    Liu Z; Li G; Gou Y; Xiao D; Luo G; Saavedra JE; Liu J; Wang H
    Biomed Pharmacother; 2017 Aug; 92():989-997. PubMed ID: 28605880
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Small hepatitis B virus surface antigen promotes malignant progression of hepatocellular carcinoma via endoplasmic reticulum stress-induced FGF19/JAK2/STAT3 signaling.
    Wu S; Ye S; Lin X; Chen Y; Zhang Y; Jing Z; Liu W; Chen W; Lin X; Lin X
    Cancer Lett; 2021 Feb; 499():175-187. PubMed ID: 33249195
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pegylated interferon alpha targets Wnt signaling by inducing nuclear export of β-catenin.
    Thompson MD; Dar MJ; Monga SP
    J Hepatol; 2011 Mar; 54(3):506-12. PubMed ID: 21093092
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IL-27, a cytokine, and IFN-λ1, a type III IFN, are coordinated to regulate virus replication through type I IFN.
    Cao Y; Zhang R; Zhang W; Zhu C; Yu Y; Song Y; Wang Q; Bai L; Liu Y; Wu K; Wu J
    J Immunol; 2014 Jan; 192(2):691-703. PubMed ID: 24337382
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NKT and CD8 lymphocytes mediate suppression of hepatocellular carcinoma growth via tumor antigen-pulsed dendritic cells.
    Shibolet O; Alper R; Zlotogarov L; Thalenfeld B; Engelhardt D; Rabbani E; Ilan Y
    Int J Cancer; 2003 Aug; 106(2):236-43. PubMed ID: 12800200
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Upregulated in Hepatitis B virus-associated hepatocellular carcinoma cells, miR-331-3p promotes proliferation of hepatocellular carcinoma cells by targeting ING5.
    Cao Y; Chen J; Wang D; Peng H; Tan X; Xiong D; Huang A; Tang H
    Oncotarget; 2015 Nov; 6(35):38093-106. PubMed ID: 26497554
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional analysis of miR-181a and Fas involved in hepatitis B virus-related hepatocellular carcinoma pathogenesis.
    Zou C; Chen J; Chen K; Wang S; Cao Y; Zhang J; Sheng Y; Huang A; Tang H
    Exp Cell Res; 2015 Feb; 331(2):352-61. PubMed ID: 25449696
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.